Hi-Tech Pharmacal Co, Inc. (NQ:HITK)
Delayed: 33.74 +0.79 (2.40%)
Trade Now!
Previous Close $32.95    52 Week High $38.17 
Open $33.06    52 Week Low $27.35 
Day High $33.94    P/E 15.00 
Day Low $32.70    EPS $2.25 
Volume 10,932,672       


May 9, 2013 07:00 AM Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Apr 30, 2013 07:01 AM ECR Pharmaceuticals Announces Re-launch of Zolpimist® and DexPak®, Divestiture of Hylase® and Orbivan® Brands, and Dr. Cameron Durrant Named President and CEO
Apr 29, 2013 07:00 AM Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare Conference
Mar 14, 2013 10:51 AM Standpoint Research Upgrades Hi Tech Pharmacal (HITK) to Buy
Mar 7, 2013 07:30 AM Hi-Tech Pharmacal Co. (HITK) Misses Q3 EPS by 28c
Dec 10, 2012 04:36 PM FMR LLC Raises Stake in Hi-Tech Pharmacal Co, Inc. (HITK) to 12.49%
Dec 7, 2012 12:54 PM Q2 Results Remove Uncertainty in Hi Tech Pharmacal (HITK)
Dec 6, 2012 12:53 PM Unusual 11 Mid-Day Movers 12/06: (BSDM) (EPHC) (MBLX) Higher; (TIGR) (LFVN) (NBY) Lower
Dec 6, 2012 07:09 AM Hi-Tech Pharmacal Co. (HITK) Tops Q2 EPS by 7c
Dec 5, 2012 03:46 PM Trading Radar for 12/06: lululemon athletica (LULU), Smithfield Foods (SFD), H&R Block (HRB), Palo Alto Networks (PANW) Report
View All Articles

Entities mentioned with HITK

View All Entities